Antibiotic resistance patterns in invasive group B streptococcal isolates

109Citations
Citations of this article
93Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Antibiotics are used for both group B streptococcal (GBS) prevention and treatment. Active population-based surveillance for invasive GBS disease was conducted in four states during 1996-2003. Of 3813 case-isolates, 91.0% (3471) were serotyped, 77.1% (2937) had susceptibility testing, and 46.6% (3471) had both. All were sensitive to penicillin, ampicillin, cefazolin, cefotaxime, and vancomycin. Clindamycin and erythromycin resistance was 12.7% and 25.6%, respectively, and associated with serotype V (P

Cite

CITATION STYLE

APA

Lynfield, R., Castor, M. L., Whitney, C. G., Como-Sabetti, K., Facklam, R. R., Ferrieri, P., … Schrag, S. J. (2008). Antibiotic resistance patterns in invasive group B streptococcal isolates. Infectious Diseases in Obstetrics and Gynecology. https://doi.org/10.1155/2008/727505

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free